GLP1R and hypertensive disorder: Compared with patients in the cohort-2020, patients in the cohort-2021 had a smaller proportion of females, larger body height, faster HR, lower eGFR, lower TG, lower GPT, a smaller proportion of patients with hypertension, and a larger proportion of GLP-1 RA use.